
Pharmaceutical Product R&D and Manufacturer

Media Financial Information Service Provider
Tokyo, January 21, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced that Eisai has been selected for the 2022 Global 100 Most Sustainable Corporations in the World list published by Canadian media and investment advisory firm Corporate Knights Inc. This marks the sixth time Eisai has been included in the ranking, placing 32nd overall and achieving the highest rank among global pharmaceutical companies.
Evaluating the sustainability of approximately 6,900 large companies globally based on various corporate initiatives in areas such as ESG (Environmental, Social, and Governance), the top 100 global companies are selected. Since 2005, the list of the world's top 100 companies has been published annually. The Global 100 is based on up to 24 key performance indicators covering ESG initiatives and is assessed using data disclosed publicly in financial documents, integrated reports, or other such channels. Eisai received high marks for its clean revenue and investments* as well as for ensuring a safe and healthy working environment for employees.
Eisai's corporate philosophy is to prioritize the interests of patients and their families, contribute to enhancing their well-being, and meet the diverse healthcare needs worldwide. Based on human health care (HHC),hhc) The corporate philosophy of Eisai is to sustainably enhance corporate value by strengthening its ESG initiatives and increasing non-financial value.
* Product sales revenue, R&D costs, and investment, such as: drugs defined by the ATM Index Foundation, adopting a fair pricing strategy and included in the WHO Essential Medicines List or used for treating any diseases, conditions, and pathogens within the therapeutic scope.